Press releases

05 Oct 2017

Regulatory Approval in Europe granted for Synthon’s glatiramer acetate 40 mg/ml

read more
13 Sep 2017

European Patent Office decides in Synthon’s favor in glatiramer patent case

read more
15 Mar 2017

Patents licensed to Synthon relating to the CD47-SIRPα pathway resist challenges in the U.S. and Europe

read more
02 Mar 2017

Synthon enters worldwide exclusive license and collaboration with Sanquin for immuno-oncology therapeutic leads modulating the CD47-SIRPα pathway

read more